OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $174,993 Invested

2012

Athira Pharma Inc.

Joseph Harding, PhD

Development of small molecule hepatoctye growth factor mimetic for the treatment of dementia.

  • Funding Amount: $174,993
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Status: Closed